Risedon Plus Tablet

Introduction

Risedon Plus Tablet 35 mg+500 mg is a combination medication used primarily to treat and prevent osteoporosis. Risedronate sodium is a bisphosphonate that helps strengthen bones and reduce the risk of fractures, while calcium is an essential mineral that supports bone health. This combination is used to manage conditions related to bone density and strength.

Uses

The primary uses of Risedon Plus Tablet 35 mg+500 mg include:

Treatment of osteoporosis in postmenopausal women to reduce the risk of fractures.
Prevention of osteoporosis in patients at high risk.
Management of osteoporosis in men.
Prevention of glucocorticoid-induced osteoporosis in patients receiving long-term corticosteroid therapy.

Brand Name	Risedon Plus
Type	Tablet
Weight	35 mg+500 mg
Generic	Risedronate Sodium + Calcium
Manufacturer	Square Pharmaceuticals Ltd.
Available in	English বাংলা

Mechanism of Action

Risedronate sodium works by inhibiting osteoclast-mediated bone resorption, which reduces the rate of bone loss and helps to maintain or increase bone density. Calcium is essential for bone mineralization and helps to support the structural integrity of the bones. The combination of these two components enhances bone strength and reduces the risk of fractures.

How Long Does It Take to Work?

Risedon Plus Tablet 35 mg+500 mg can start to show effects on bone density within 3 to 6 months of therapy. However, the full benefits, including reduced fracture risk, may take longer to become apparent, often around 1 to 2 years of consistent use.

Absorption

Risedronate sodium is absorbed in the gastrointestinal tract, but its absorption is significantly affected by food and other medications. Calcium is also absorbed in the gastrointestinal tract, with its absorption optimized in the presence of adequate vitamin D. For optimal absorption of risedronate, it should be taken on an empty stomach with a full glass of water.

Route of Elimination

Risedronate sodium is primarily eliminated through the kidneys. It is not extensively metabolized, and its effects on bone resorption are mediated through its direct action on bone tissues. Calcium is excreted via the kidneys, and its levels in the body are tightly regulated to maintain bone health and other physiological functions.

Dosage

The typical dosage of Risedon Plus Tablet 35 mg+500 mg is:

Risedronate Sodium: 5 mg daily, or 35 mg weekly, or 150 mg monthly.
Calcium: 1000-1200 mg daily, usually divided into two or three doses throughout the day.

Administration

Risedon Plus Tablet 35 mg+500 mg should be taken according to the prescribed schedule, either daily, weekly, or monthly, depending on the specific formulation. It should be taken with a full glass of water, preferably in the morning, and at least 30 minutes before eating or taking any other medications to maximize absorption. Calcium supplements can be taken with meals to improve absorption.

Side Effects

Common side effects may include:

Gastrointestinal symptoms such as nausea, abdominal pain, and dyspepsia.
Musculoskeletal pain.
Headache.

Less common side effects include esophageal irritation or ulceration and atypical femoral fractures. Calcium supplementation may cause constipation or kidney stones in some individuals.

Toxicity

Toxicity from Risedon Plus Tablet 35 mg+500 mg is rare but can occur. Overdosing on risedronate can lead to severe gastrointestinal symptoms and bone pain. Excessive calcium intake can result in hypercalcemia, which may cause nausea, vomiting, and kidney stones. Regular monitoring of calcium levels and kidney function is advised during treatment.

Precautions

Precautions include:

Ensuring proper renal function before starting therapy, as impaired kidney function can affect drug elimination.
Monitoring for signs of gastrointestinal irritation or ulcers.
Assessing the risk of esophageal disorders, as risedronate can cause esophageal irritation.

Interaction

Risedronate sodium may interact with:

Antacids and other medications that affect gastrointestinal pH, which can impair absorption.
Calcium supplements and multivitamins containing calcium should be taken at different times from risedronate to avoid interference with absorption.

Calcium supplements may interact with certain medications, such as antibiotics and bisphosphonates, affecting their absorption and effectiveness.

Disease Interaction

Use with caution in patients with:

Renal impairment or chronic kidney disease.
Gastrointestinal disorders such as esophagitis or ulcers.
Hyperparathyroidism or other metabolic bone diseases.

Drug Interaction

Risedronate sodium may interact with:

Nonsteroidal anti-inflammatory drugs (NSAIDs) and aspirin, which may exacerbate gastrointestinal side effects.
Certain antacids or supplements, including calcium, magnesium, and iron, which can reduce the effectiveness of risedronate.

Calcium supplements can interfere with the absorption of other medications, such as bisphosphonates and certain antibiotics.

Food Interactions

Food can significantly affect the absorption of risedronate sodium. To ensure optimal absorption, it should be taken on an empty stomach, and patients should avoid consuming food or drinks (other than water) for at least 30 minutes after taking the medication. Calcium supplements are best taken with meals to enhance absorption.

Pregnancy Use

The use of Risedon Plus Tablet 35 mg+500 mg during pregnancy is not recommended unless the benefits outweigh the risks. Risedronate is classified as a Category C drug, meaning that risk cannot be ruled out. Consult with a healthcare provider for alternatives or specific guidance if pregnancy occurs during treatment.

Lactation Use

Risedronate sodium is excreted in breast milk in small amounts. The use of Risedon Plus Tablet 35 mg+500 mg during lactation should be carefully considered. Consult with a healthcare provider to assess the risks and benefits and explore alternative treatments if necessary.

Acute Overdose

Acute overdose of Risedon Plus Tablet 35 mg+500 mg may cause severe gastrointestinal symptoms, including nausea, vomiting, and abdominal pain. Excessive calcium intake can lead to hypercalcemia, causing symptoms such as confusion, muscle weakness, and kidney stones. Seek immediate medical attention in case of overdose.

Contraindication

Contraindications include:

Severe renal impairment or renal failure.
Esophageal abnormalities that may impede swallowing or increase the risk of esophageal irritation.
Known hypersensitivity to risedronate sodium or any other components of the formulation.

Use Direction

Follow the prescribed dosing schedule for Risedon Plus Tablet 35 mg+500 mg. Take risedronate on an empty stomach with a full glass of water, and avoid eating or drinking for at least 30 minutes afterward. Take calcium supplements as directed, typically with meals. Adhere to regular follow-up appointments to monitor bone density and overall health.

Storage Conditions

Store Risedon Plus Tablet 35 mg+500 mg at room temperature, away from moisture and direct light. Keep the medication in its original container to protect it from light and moisture. Follow any additional storage instructions provided by the manufacturer.

Volume of Distribution

Risedronate sodium has a low volume of distribution as it primarily binds to bone tissues and is retained in the skeletal system. Calcium is widely distributed throughout the body, with a significant portion found in bones and teeth.

Half Life

The half-life of risedronate sodium in the body is approximately 1 hour in plasma. However, its effects on bone resorption can last for months due to its binding to bone tissues. The half-life of calcium in the body is not typically measured as it is continuously regulated and distributed in the bones, blood, and tissues.

Clearance

Risedronate sodium is primarily cleared by the kidneys. The rate of clearance is influenced by renal function. Calcium clearance is also primarily through the kidneys, with its excretion regulated to maintain homeostasis.

See in details version Risedon Plus Tablet 35 mg+500 mg also Risedon Plus Tablet 35 mg+500 mg in bangla